<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nonatheromatous popliteal artery diseases causing claudication or limb-threatening ischemia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nonatheromatous popliteal artery diseases causing claudication or limb-threatening ischemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nonatheromatous popliteal artery diseases causing claudication or limb-threatening ischemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Matthew R Smeds, MD, FACS, DFSVS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Caitlin W Hicks, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2063362634"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nonatheromatous popliteal artery diseases that can cause symptoms of claudication or, rarely, limb-threatening ischemia predominantly include popliteal artery entrapment syndrome and adventitial cystic disease. Affected patients are typically younger compared with those affected by peripheral artery disease and lack typical risk factors associated with atherosclerosis. </p><p>Treatment of symptomatic patients generally requires an open surgical approach to manage the vascular abnormality, although for some patients, medical management may be an option.</p><p>The clinical features, diagnosis, and treatment of nonatheromatous popliteal artery disease are reviewed. </p><p>The clinical features, diagnosis, and management of atherosclerotic lower extremity disease are reviewed elsewhere. Popliteal artery aneurysm is also reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/95282.html" rel="external">"Overview of lower extremity peripheral artery disease"</a> and  <a class="medical medical_review" href="/z/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease"</a> and  <a class="medical medical_review" href="/z/d/html/8210.html" rel="external">"Management of claudication due to peripheral artery disease"</a> and  <a class="medical medical_review" href="/z/d/html/15187.html" rel="external">"Popliteal artery aneurysm"</a> and  <a class="medical medical_review" href="/z/d/html/15221.html" rel="external">"Surgical and endovascular repair of popliteal artery aneurysm"</a>.)</p><p class="headingAnchor" id="H2477632848"><span class="h1">ANATOMIC CONSIDERATIONS</span><span class="headingEndMark"> — </span>The popliteal artery is a continuation of the femoral artery as it exits the adductor canal (Hunter canal), which is the aponeurotic passageway from the anterior thigh to posterior leg  (<a class="graphic graphic_figure graphicRef62362" href="/z/d/graphic/62362.html" rel="external">figure 1</a>). Within the popliteal fossa, the popliteal artery is the deepest structure and lies adjacent the knee joint capsule. Multiple geniculate branches provide blood supply to the knee joint  (<a class="graphic graphic_figure graphicRef72956" href="/z/d/graphic/72956.html" rel="external">figure 2</a>) as well as provide collateral flow to the leg during maximal knee flexion. Important muscles relevant to the pathologies discussed below (popliteal artery entrapment syndrome, adventitial cystic disease) include the popliteus muscle, which normally lies anterior to the popliteal artery, and the medial head of the gastrocnemius muscle of the calf, which lies medially in the distal portion of the popliteal space.</p><p class="headingAnchor" id="H1887606369"><span class="h1">CLINICAL FEATURES AND DIAGNOSIS</span><span class="headingEndMark"> — </span>The clinical presentation of nonatheromatous popliteal disease is primarily intermittent claudication (derived from the Latin word for limp), which is defined as a reproducible discomfort in a muscle group induced by exercise and relieved with rest. The severity of claudication symptoms depends upon the degree of obstruction, the effectiveness of the collateral circulation, and the level of exercise.</p><p class="headingAnchor" id="H137687588"><span class="h2">Diagnosis of vascular obstruction</span><span class="headingEndMark"> — </span>Most patients with symptoms of claudication undergo noninvasive vascular testing, including physiologic testing with or without duplex ultrasound. Symptomatic patients with nonatheromatous popliteal disease often have normal ankle-brachial index values at rest but will have abnormal studies following exercise. As such, the first step in the evaluation of a patient with claudication and suspected nonatheromatous arterial disease should be exercise testing. (See  <a class="medical medical_review" href="/z/d/html/8201.html" rel="external">"Noninvasive diagnosis of upper and lower extremity arterial disease", section on 'Exercise testing'</a>.)</p><p>Imaging confirms vascular obstruction and etiology. </p><p class="headingAnchor" id="H2161417682"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of nonatherosclerotic popliteal artery disease is primarily obstruction due to atherosclerosis (ie, peripheral artery disease [PAD]) causing claudication or other atypical symptoms. However, while PAD typically presents later in life, a subset of younger patients with more aggressive disease does exist. However, patients with PAD most often have typical risk factors for atherosclerotic disease (eg, smoking, hypertension, dyslipidemia, diabetes, chronic kidney disease), which are typically absent in those with nonatheromatous disease. (See  <a class="medical medical_review" href="/z/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease"</a>.)</p><p>Nonatheromatous popliteal artery diseases often affect younger people, and the differential diagnosis is often quite broad  (<a class="graphic graphic_table graphicRef131876" href="/z/d/graphic/131876.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. Claudication symptoms can frequently be mistaken for symptoms related to muscle strains or tears, stress fractures, or chronic compartment syndrome in affected younger patients [<a href="#rid2">2</a>]. In addition, patients with nonatheromatous vascular disease often have palpable pedal pulses at rest, which further confuses the issue [<a href="#rid3">3</a>]. Endofibrosis is another nonatheromatous arterial disease that affects the iliac artery related to repetitive trauma usually due to athletic activities [<a href="#rid4">4</a>].</p><p>Popliteal venous compression can coexist with nonatheromatous arterial diseases. Popliteal venous entrapment syndrome as an isolated entity is much less common compared with popliteal artery entrapment syndrome [<a href="#rid5">5,6</a>]. Other conditions that can cause lower extremity edema, which can be associated with nonatheromatous arterial diseases, include deep venous thrombosis and chronic venous insufficiency. In a young patient with unilateral swelling and no other risk factors for venous thrombosis, iliac vein obstruction should be considered. (See  <a class="medical medical_review" href="/z/d/html/6878.html" rel="external">"Clinical manifestations and evaluation of edema in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease"</a> and  <a class="medical medical_review" href="/z/d/html/1351.html" rel="external">"Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity"</a> and  <a class="medical medical_review" href="/z/d/html/110055.html" rel="external">"May-Thurner syndrome"</a>.)</p><p class="headingAnchor" id="H1006478859"><span class="h1">SPECIFIC SYNDROMES</span><span class="headingEndMark"> — </span>While symptoms of ischemia and the general approach to evaluation are similar for nonatherosclerotic popliteal disease, treatment and prognosis are specific to each</p><p>syndrome. The most common nonatheromatous popliteal artery diseases, popliteal artery entrapment syndrome and adventitial cystic disease, are reviewed in detail below; other less common etiologies are briefly listed with links to separate topic reviews. (See <a class="local">'Other nonatheromatous popliteal diseases'</a> below.)</p><p class="headingAnchor" id="H2018882561"><span class="h2">Popliteal artery entrapment syndrome</span><span class="headingEndMark"> — </span>Popliteal artery entrapment syndrome (PAES) is a condition in which there is an abnormal anatomic relationship between the neurovascular structure of the popliteal fossa and nearby musculotendinous structures. Popliteal artery entrapment is the most common form, and popliteal artery compression by one of the calf muscles can reduce blood flow to the leg, causing ischemic symptoms. Symptoms of PAES are usually chronic, but acute limb ischemia (ALI) can also occur. </p><p class="bulletIndent1"><span class="glyph">●</span>PAES can occur as either a congenital or acquired condition. In the congenital form (types I to VI), one of the calf muscles develops in an abnormal position during fetal development, resulting in displacement or compression of the popliteal artery. In the acquired form of PAES (types F), one of the calf muscles becomes enlarged, resulting in compression of the popliteal artery. The acquired form is commonly referred to as functional PAES. (See  <a class="medical medical_review" href="/z/d/html/142680.html" rel="external">"Popliteal entrapment syndromes", section on 'Classifications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with PAES are typically young and male without atherosclerotic risk factors such as smoking, hypertension, hypercholesterolemia, and diabetes [<a href="#rid7">7</a>]. Symptomatic patients typically complain of classic intermittent claudication related to arterial compression [<a href="#rid8">8,9</a>]. ALI occurs in approximately 11 percent of patients [<a href="#rid8">8</a>]. Many cases are bilateral, although the exact prevalence of bilateral PAES is unknown (25 to 83 percent in the available literature [<a href="#rid8">8-10</a>]). (See  <a class="medical medical_review" href="/z/d/html/142680.html" rel="external">"Popliteal entrapment syndromes", section on 'Clinical presentations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Duplex ultrasound can be used to establish a diagnosis of PAES. Cross-sectional imaging using CT or MR angiography will show the anatomic relationship neurovascular structures in the popliteal fossa to the gastrocnemius muscle. Surgical decompression of the popliteal space is the mainstay of treatment for symptomatic PAES. (See  <a class="medical medical_review" href="/z/d/html/142680.html" rel="external">"Popliteal entrapment syndromes", section on 'Management approach'</a> and  <a class="medical medical_review" href="/z/d/html/142680.html" rel="external">"Popliteal entrapment syndromes", section on 'Summary and recommendations'</a>.)</p><p></p><p class="headingAnchor" id="H429331037"><span class="h2">Adventitial cystic disease</span><span class="headingEndMark"> — </span>Adventitial cystic disease (ACD) is a condition of unknown etiology that results in cysts containing gelatinous mucoid material located between the adventitial and medial layers of the artery, causing luminal stenosis or occlusion [<a href="#rid11">11</a>]. The cysts are usually unilocular, lack a cellular lining, and contain hyaluronic acid, protein, and proteoglycans [<a href="#rid12">12,13</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with lower extremity ACD most commonly present with unilateral intermittent calf claudication [<a href="#rid14">14</a>]. The right and left lower extremity are affected with similar frequency [<a href="#rid15">15</a>]. As compared with PAD, however, patients with ACD and claudication frequently have prolonged post-exercise recovery time before pain resolution and may report a waxing and waning of symptoms due to fluctuating amounts of cyst content present at any given time. Patients can also present with ALI, pain, paresthesias, or a palpable tissue masses [<a href="#rid14">14</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>While ACD should be considered in any patient lacking typical cardiovascular risk factors but presenting with claudication symptoms, particularly in younger patients. Vascular imaging can demonstrate the cystic lesion(s) of the affected artery and the severity of any associated stenosis or complete occlusion [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/17031.html" rel="external">"Adventitial cystic disease", section on 'Clinical presentations'</a> and  <a class="medical medical_review" href="/z/d/html/17031.html" rel="external">"Adventitial cystic disease", section on 'Diagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatment of symptomatic patients is warranted to prevent progression to a fixed lesion or to prevent limb-threatening ischemia due to thrombosis of the stenotic segment of the artery. Options for treatment include cyst aspiration, which is associated with recurrence in up to half of patients, or cyst excision with or without vascular reconstruction depending on the extent of the cystic changes [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/z/d/html/17031.html" rel="external">"Adventitial cystic disease", section on 'Treatment'</a>.)</p><p></p><p class="headingAnchor" id="H1860465054"><span class="h2">Other nonatheromatous popliteal diseases</span><span class="headingEndMark"> — </span>Other nonatheromatous diseases that can affect the popliteal artery and cause ischemic lower extremity symptoms include the following [<a href="#rid17">17,18</a>]:</p><p class="headingAnchor" id="H3380191136"><span class="h3">Fibromuscular dysplasia</span><span class="headingEndMark"> — </span>Fibromuscular dysplasia (FMD) most commonly affects the renal arteries and extracranial cerebrovascular arteries, but it can affect the popliteal artery, leading to ischemic symptoms due to embolism or related to formation of popliteal aneurysm. (See  <a class="medical medical_review" href="/z/d/html/3874.html" rel="external">"Clinical manifestations and diagnosis of fibromuscular dysplasia"</a> and  <a class="medical medical_review" href="/z/d/html/15187.html" rel="external">"Popliteal artery aneurysm"</a>.)</p><p class="headingAnchor" id="H1210995393"><span class="h3">Thromboangiitis obliterans (buerger disease)</span><span class="headingEndMark"> — </span>Thromboangiitis obliterans (TAO) more typically affects the small vessels of the hands and feet. Large artery involvement can occur, but when it does, it rarely occurs in the absence of small vessel occlusive disease. Cannabis can lead to a vasculitis that is clinically similar to TAO [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/8205.html" rel="external">"Thromboangiitis obliterans (Buerger disease)"</a> and  <a class="medical medical_review" href="/z/d/html/7797.html" rel="external">"Cannabis use and disorder: Epidemiology, pharmacology, comorbidities, and adverse effects"</a>.)</p><p class="headingAnchor" id="H2890832257"><span class="h3">Medium and large vessel vasculitis</span><span class="headingEndMark"> — </span>Arterial involvement occurs in 10 to 30 percent of patients with Behcet syndrome, largely related to aneurysm formation [<a href="#rid18">18</a>]. Other forms of vasculitis more typically involve the vessels of the upper extremity, but rarely the lower extremities can be involved [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">"Clinical manifestations and diagnosis of Behçet syndrome", section on 'Arterial disease'</a> and  <a class="medical medical_review" href="/z/d/html/8226.html" rel="external">"Overview of and approach to the vasculitides in adults"</a> and  <a class="medical medical_review" href="/z/d/html/15187.html" rel="external">"Popliteal artery aneurysm"</a>.)</p><p class="headingAnchor" id="H3564038275"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118637.html" rel="external">"Society guideline links: Acute extremity ischemia"</a>.)</p><p class="headingAnchor" id="H2351518774"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonatheromatous arterial diseases</strong> – Nonatheromatous popliteal artery diseases are uncommon conditions and include predominantly popliteal artery entrapment syndrome (PAES) and adventitial cystic disease (ACD). Affected patients are typically younger compared with those affected by peripheral artery disease (PAD) and lack typical risk factors associated with atherosclerosis. (See <a class="local">'Clinical features and diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Popliteal artery entrapment syndrome</strong> – Popliteal artery entrapment syndrome (PAES) is due to an abnormal anatomic relationship between the neurovascular structures of the popliteal fossa and nearby musculotendinous structures that can be congenital or acquired. PAES can be bilateral. PAES is classified based on the relationship of the medial head of the gastrocnemius muscle with the vascular structures, predominantly the popliteal artery. (See <a class="local">'Popliteal artery entrapment syndrome'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Adventitial cystic disease</strong> – ACD is a condition of unknown etiology that results in cysts containing gelatinous mucoid material located between the adventitia and medial layers of the artery causing luminal stenosis or occlusion. ACD is more common in males compared with females and typically presents in the fourth or fifth decade of life. (See <a class="local">'Adventitial cystic disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features and diagnosis</strong> – Nonatheromatous popliteal artery disease can reduce perfusion to the extremity typically causing chronic ischemic symptoms, but acute limb ischemia or other related symptoms can also occur. Patients with nonatheromatous popliteal disease predominantly present with intermittent claudication, which a reproducible discomfort in a muscle group induced by exercise and relieved with rest. Other symptoms include paresthesias, or limb swelling related to nerve or venous compression, respectively. Symptomatic patients often have normal ankle-brachial index (ABI) values at rest, but with exercise testing, ABI values markedly decrease. Vascular imaging (eg, ultrasound, cross-sectional imaging, angiography) confirms the diagnosis. (See <a class="local">'Clinical features and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of nonatherosclerotic disease is primarily obstruction due to atherosclerosis (ie, PAD) causing claudication or other atypical symptoms. Because nonatheromatous popliteal artery diseases usually affects younger people, the differential diagnosis of exertional leg pain is broad  (<a class="graphic graphic_table graphicRef131876" href="/z/d/graphic/131876.html" rel="external">table 1</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong>– Patients who are asymptomatic do not require treatment. For symptomatic patients, treatment generally requires an open surgical approach to manage the vascular abnormality, although for some patients less invasive therapy, though not endovascular therapy, may be an option (eg, botulinum toxin for PAES; cyst aspiration for ACD). Long-term patency rates following surgical management of nonatheromatous arterial disease in the absence of thrombosis are generally excellent. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Surgical treatment of PAES involves decompression of the popliteal space with reconstruction of the artery, if damaged. (See <a class="local">'Popliteal artery entrapment syndrome'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Surgical treatment of ACD involves surgical excision of the cyst and interposition grafting using saphenous vein reconstruction. (See <a class="local">'Adventitial cystic disease'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hislop M, Kennedy D, Cramp B, Dhupelia S. Functional Popliteal Artery Entrapment Syndrome: Poorly Understood and Frequently Missed? A Review of Clinical Features, Appropriate Investigations, and Treatment Options. J Sports Med 2014.</a></li><li><a class="nounderline abstract_t">Hicks CW, Black JH 3rd, Ratchford EV. Popliteal artery entrapment syndrome. Vasc Med 2019; 24:190.</a></li><li><a class="nounderline abstract_t">Hameed M, Coupland A, Davies AH. Popliteal artery entrapment syndrome: an approach to diagnosis and management. Br J Sports Med 2018; 52:1073.</a></li><li><a class="nounderline abstract_t">Korngold EC, Jaff MR. Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosis. Curr Treat Options Cardiovasc Med 2009; 11:156.</a></li><li><a class="nounderline abstract_t">Leon M, Volteas N, Labropoulos N, et al. Popliteal vein entrapment in the normal population. Eur J Vasc Surg 1992; 6:623.</a></li><li><a class="nounderline abstract_t">Erdoes LS, Devine JJ, Bernhard VM, et al. Popliteal vascular compression in a normal population. J Vasc Surg 1994; 20:978.</a></li><li><a class="nounderline abstract_t">Ratchford EV, Evans NS. Vascular Disease Patient Information Page: Peripheral artery disease. Vasc Med 2014; 19:218.</a></li><li><a class="nounderline abstract_t">Shahi N, Arosemena M, Kwon J, et al. Functional Popliteal Artery Entrapment Syndrome: A Review of Diagnosis and Management. Ann Vasc Surg 2019; 59:259.</a></li><li><a class="nounderline abstract_t">Levien LJ, Veller MG. Popliteal artery entrapment syndrome: more common than previously recognized. J Vasc Surg 1999; 30:587.</a></li><li><a class="nounderline abstract_t">Stager A, Clement D. Popliteal artery entrapment syndrome. Sports Med 1999; 28:61.</a></li><li><a class="nounderline abstract_t">Lezotte J, Le QP, Shanley C, Hans S. Adventitial Cystic Disease: Complicated and Uncomplicated. Ann Vasc Surg 2018; 46:370.e13.</a></li><li><a class="nounderline abstract_t">Jay GD, Ross FL, Mason RA, Giron F. Clinical and chemical characterization of an adventitial popliteal cyst. J Vasc Surg 1989; 9:448.</a></li><li><a class="nounderline abstract_t">di Marzo L, Della Rocca C, d'Amati G, et al. Cystic adventitial degeneration of the popliteal artery: lectin-histochemical study. Eur J Vasc Surg 1994; 8:16.</a></li><li><a class="nounderline abstract_t">Lejay A, Ohana M, Delay C, et al. Cystic adventitial pathology as an entity in peripheral arterial disease. J Cardiovasc Surg (Torino) 2016; 57:282.</a></li><li><a class="nounderline abstract_t">Desy NM, Spinner RJ. The etiology and management of cystic adventitial disease. J Vasc Surg 2014; 60:235.</a></li><li><a class="nounderline abstract_t">Jeong S, Kwon TW, Han Y, Cho YP. Effectiveness of Surgical Treatment with Complete Cyst Excision for Cystic Adventitial Disease of the Popliteal Artery. Ann Vasc Surg 2021; 72:261.</a></li><li><a class="nounderline abstract_t">Peyrot I, Garsaud AM, Saint-Cyr I, et al. Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol 2007; 21:388.</a></li><li><a class="nounderline abstract_t">Mintz AJ, Weinberg I. Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities. Curr Cardiol Rep 2015; 17:66.</a></li><li><a class="nounderline abstract_t">Celecova Z, Krahulec B, Lizicarova D, Gaspar L. Vasculitides as a rare cause of intermittent claudication. Bratisl Lek Listy 2013; 114:353.</a></li></ol></div><div id="topicVersionRevision">Topic 15209 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26464888" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Functional Popliteal Artery Entrapment Syndrome: Poorly Understood and Frequently Missed? A Review of Clinical Features, Appropriate Investigations, and Treatment Options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30739583" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Popliteal artery entrapment syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29351946" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Popliteal artery entrapment syndrome: an approach to diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19289028" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1451818" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Popliteal vein entrapment in the normal population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7990194" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Popliteal vascular compression in a normal population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24879717" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Vascular Disease Patient Information Page: Peripheral artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31028851" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Functional Popliteal Artery Entrapment Syndrome: A Review of Diagnosis and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10514198" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Popliteal artery entrapment syndrome: more common than previously recognized.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10461713" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Popliteal artery entrapment syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28911964" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Adventitial Cystic Disease: Complicated and Uncomplicated.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2921793" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical and chemical characterization of an adventitial popliteal cyst.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8307209" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Cystic adventitial degeneration of the popliteal artery: lectin-histochemical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26471959" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cystic adventitial pathology as an entity in peripheral arterial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24970659" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The etiology and management of cystic adventitial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32946995" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effectiveness of Surgical Treatment with Complete Cyst Excision for Cystic Adventitial Disease of the Popliteal Artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17309465" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cannabis arteritis: a new case report and a review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26162862" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23731050" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Vasculitides as a rare cause of intermittent claudication.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
